These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure. Di Campli C, Santoro MC, Gaspari R, Merra G, Zileri Dal Verme L, Zocco MA, Piscaglia AC, Di Gioacchino G, Novi M, Santoliquido A, Flore R, Tondi P, Proietti R, Gasbarrini G, Pola P, Gasbarrini A. Transplant Proc; 2005; 37(6):2547-50. PubMed ID: 16182739 [Abstract] [Full Text] [Related]
9. Cerebral hemodynamic and metabolic profiles in fulminant hepatic failure: relationship to outcome. Aggarwal S, Obrist W, Yonas H, Kramer D, Kang Y, Scott V, Planinsic R. Liver Transpl; 2005 Nov; 11(11):1353-60. PubMed ID: 16237715 [Abstract] [Full Text] [Related]
13. [Development of extracorporeal blood purification methods: Molecular Adsorbent Recirculating System (MARS) for hepatic and renal function replacement]. Marangoni R. G Ital Nefrol; 2007 Nov; 24 Suppl 38():92-6. PubMed ID: 17922457 [Abstract] [Full Text] [Related]
14. Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system. Tan HK, Yang WS, Chow P, Lui HF, Choong HL, Wong KS. Artif Organs; 2007 Mar; 31(3):193-9. PubMed ID: 17343694 [Abstract] [Full Text] [Related]
15. Preconditioning by extracorporeal liver support (MARS) of patients with cirrhosis and severe liver failure evaluated for living donor liver transplantation -- a pilot study. Choi JY, Bae SH, Yoon SK, Cho SH, Yang JM, Han JY, Ahn BM, Chung KW, Sun HS, Kim DG. Liver Int; 2005 Aug; 25(4):740-5. PubMed ID: 15998424 [Abstract] [Full Text] [Related]
16. Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent recirculating system while on the waiting list: impact of the duration of therapy. Camus C, Lavoué S, Gacouin A, Compagnon P, Boudjéma K, Jacquelinet C, Thomas R, Le Tulzo Y. Ther Apher Dial; 2009 Dec; 13(6):549-55. PubMed ID: 19954480 [Abstract] [Full Text] [Related]
17. Mars and Prometheus: our clinical experience in acute chronic liver failure. Faenza S, Baraldi O, Bernardi M, Bolondi L, Coli L, Cucchetti A, Donati G, Gozzetti F, Lauro A, Mancini E, Pinna AD, Piscaglia F, Rasciti L, Ravaioli M, Ruggeri G, Santoro A, Stefoni S. Transplant Proc; 2008 May; 40(4):1169-71. PubMed ID: 18555140 [Abstract] [Full Text] [Related]
18. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R, Nöldge-Schomburg G. J Am Soc Nephrol; 2001 Feb; 12 Suppl 17():S75-82. PubMed ID: 11251037 [Abstract] [Full Text] [Related]
19. Use of molecular adsorbent recirculating system in acute liver failure attributable to dengue hemorrhagic fever. Penafiel A, Devanand A, Tan HK, Eng P. J Intensive Care Med; 2006 Feb; 21(6):369-71. PubMed ID: 17095501 [Abstract] [Full Text] [Related]
20. One hundred sixteen cases of acute liver failure treated with MARS. Novelli G, Rossi M, Pretagostini M, Pugliese F, Ruberto F, Novelli L, Nudo F, Bussotti A, Corradini S, Martelli S, Berloco PB. Transplant Proc; 2005 Feb; 37(6):2557-9. PubMed ID: 16182742 [Abstract] [Full Text] [Related] Page: [Next] [New Search]